472 related articles for article (PubMed ID: 33814126)
1. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
Beguería R; García D; Vassena R; Rodríguez A
Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology.
Yildiz S; Turkgeldi E; Angun B; Eraslan A; Urman B; Ata B
Fertil Steril; 2019 Oct; 112(4):677-683. PubMed ID: 31371053
[TBL] [Abstract][Full Text] [Related]
4. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
5. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
7. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
[TBL] [Abstract][Full Text] [Related]
8. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
[TBL] [Abstract][Full Text] [Related]
10. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
11. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
Wang Y; Chen Q; Wang N; Chen H; Lyu Q; Kuang Y
Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
Wang Y; Kuang Y; Chen Q; Cai R
Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
[TBL] [Abstract][Full Text] [Related]
13. Oral medroxyprogesterone acetate for the use of ovulation suppression in in vitro fertilization: a cohort trial.
Welp AM; Williams CD; Smith LP; Purcell S; Goodman LR
Fertil Steril; 2024 May; 121(5):806-813. PubMed ID: 38253117
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
15. Fixed Gonadotropin-Releasing Hormone Antagonist Protocol
Dong M; Sun L; Huang L; Wang F; Zhang X; Liu F
Front Endocrinol (Lausanne); 2021; 12():690575. PubMed ID: 34867773
[TBL] [Abstract][Full Text] [Related]
16. Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles.
Tandulwadkar S; Gupta S; Singh A; Mishra S; Singhania S
JBRA Assist Reprod; 2023 Mar; 27(1):15-19. PubMed ID: 35621299
[TBL] [Abstract][Full Text] [Related]
17. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
[TBL] [Abstract][Full Text] [Related]
18. Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle.
Glujovsky D; Pesce R; Miguens M; Sueldo C; Ciapponi A
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD013827. PubMed ID: 38032057
[TBL] [Abstract][Full Text] [Related]
19. Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?
Martínez F; Clúa E; García S; Coroleu B; Polyzos NP; Barri PN
Reprod Biomed Online; 2020 May; 40(5):661-667. PubMed ID: 32268981
[TBL] [Abstract][Full Text] [Related]
20. Ovarian stimulation for oocyte donation: a systematic review and meta-analysis.
Martinez F; Racca A; Rodríguez I; Polyzos NP
Hum Reprod Update; 2021 Jun; 27(4):673-696. PubMed ID: 33742206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
